These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22554253)

  • 81. [Aβ42 gene vaccine for prevention and treatment of Alzheimer's disease].
    Rosenberg RN
    Rinsho Shinkeigaku; 2010 Nov; 50(11):838. PubMed ID: 21921464
    [No Abstract]   [Full Text] [Related]  

  • 82. Analysis of three plasmid systems for use in DNA A beta 42 immunization as therapy for Alzheimer's disease.
    Qu BX; Lambracht-Washington D; Fu M; Eagar TN; Stüve O; Rosenberg RN
    Vaccine; 2010 Jul; 28(32):5280-7. PubMed ID: 20562015
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology.
    Serrano-Pozo A; William CM; Ferrer I; Uro-Coste E; Delisle MB; Maurage CA; Hock C; Nitsch RM; Masliah E; Growdon JH; Frosch MP; Hyman BT
    Brain; 2010 May; 133(Pt 5):1312-27. PubMed ID: 20360050
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Development of a new DNA vaccine for Alzheimer disease targeting a wide range of aβ species and amyloidogenic peptides.
    Matsumoto Y; Niimi N; Kohyama K
    PLoS One; 2013; 8(9):e75203. PubMed ID: 24086465
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Reduced effectiveness of Abeta1-42 immunization in APP transgenic mice with significant amyloid deposition.
    Das P; Murphy MP; Younkin LH; Younkin SG; Golde TE
    Neurobiol Aging; 2001; 22(5):721-7. PubMed ID: 11705631
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Microglial motility in Alzheimer's disease and after Aβ42 immunotherapy: a human post-mortem study.
    Franco-Bocanegra DK; George B; Lau LC; Holmes C; Nicoll JAR; Boche D
    Acta Neuropathol Commun; 2019 Nov; 7(1):174. PubMed ID: 31703599
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The conformational epitope for a new Aβ42 protofibril-selective antibody partially overlaps with the peptide N-terminal region.
    Colvin BA; Rogers VA; Kulas JA; Ridgway EA; Amtashar FS; Combs CK; Nichols MR
    J Neurochem; 2017 Dec; 143(6):736-749. PubMed ID: 28881033
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease.
    Qu B; Rosenberg RN; Li L; Boyer PJ; Johnston SA
    Arch Neurol; 2004 Dec; 61(12):1859-64. PubMed ID: 15596606
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice.
    Sigurdsson EM; Scholtzova H; Mehta PD; Frangione B; Wisniewski T
    Am J Pathol; 2001 Aug; 159(2):439-47. PubMed ID: 11485902
    [TBL] [Abstract][Full Text] [Related]  

  • 90. CD40L disruption enhances Abeta vaccine-mediated reduction of cerebral amyloidosis while minimizing cerebral amyloid angiopathy and inflammation.
    Obregon D; Hou H; Bai Y; Nikolic WV; Mori T; Luo D; Zeng J; Ehrhart J; Fernandez F; Morgan D; Giunta B; Town T; Tan J
    Neurobiol Dis; 2008 Feb; 29(2):336-53. PubMed ID: 18055209
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Simvastatin enhances immune responses to Aβ vaccination and attenuates vaccination-induced behavioral alterations.
    Kou J; Kim HD; Jin J; Cao D; Li L; Lalonde R; Fukuchi K
    Brain Res; 2010 Oct; 1356():102-11. PubMed ID: 20691674
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Combined treatment of Aβ immunization with statin in a mouse model of Alzheimer's disease.
    Kou J; Song M; Pattanayak A; Lim JE; Yang J; Cao D; Li L; Fukuchi K
    J Neuroimmunol; 2012 Mar; 244(1-2):70-83. PubMed ID: 22326143
    [TBL] [Abstract][Full Text] [Related]  

  • 93. DNA Aβ42 vaccination as possible alternative immunotherapy for Alzheimer disease.
    Rosenberg RN; Lambracht-Washington D
    JAMA Neurol; 2013 Jun; 70(6):772-3. PubMed ID: 23700123
    [No Abstract]   [Full Text] [Related]  

  • 94. Off-target binding of an anti-amyloid beta monoclonal antibody to platelet factor 4 causes acute and chronic toxicity in cynomolgus monkeys.
    Loberg LI; Chhaya M; Ibraghimov A; Tarcsa E; Striebinger A; Popp A; Huang L; Oellien F; Barghorn S
    MAbs; 2021; 13(1):1887628. PubMed ID: 33596779
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Amyloid-β targeting immunisation in aged non-human primate (Microcebus murinus).
    Trouche SG; Boutajangout A; Asuni A; Fontés P; Sigurdsson EM; Verdier JM; Mestre-Francés N
    Brain Behav Immun; 2023 Mar; 109():63-77. PubMed ID: 36592872
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Delivery of the Brainshuttle™ amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans.
    Grimm HP; Schumacher V; Schäfer M; Imhof-Jung S; Freskgård PO; Brady K; Hofmann C; Rüger P; Schlothauer T; Göpfert U; Hartl M; Rottach S; Zwick A; Seger S; Neff R; Niewoehner J; Janssen N
    MAbs; 2023; 15(1):2261509. PubMed ID: 37823690
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The Impact of Ageing on the CNS Immune Response in Alzheimer's Disease.
    Chee SEJ; Solito E
    Front Immunol; 2021; 12():738511. PubMed ID: 34603320
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Intracellular tracing of amyloid vaccines through direct fluorescent labelling.
    Mold M; Kumar M; Mirza A; Shardlow E; Exley C
    Sci Rep; 2018 Feb; 8(1):2437. PubMed ID: 29402930
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Age-related cognitive impairment is associated with low serum concentrations of testosterone and CSF levels of amyloid beta 42 in male cynomolgus monkeys (Macaca fascicularis).
    Darusman HS; Li Wern T; Sajuthi D; Schapiro SJ; Hau J
    J Med Primatol; 2021 Oct; 50(5):270-272. PubMed ID: 34363401
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The neuroprotective effect of immune serum of adeno-associated virus vaccine containing Aβ1-15 gene on amyloid toxicity.
    Liu LY; Ma YY; Yang T; Li X; Li W
    Ann Indian Acad Neurol; 2013 Oct; 16(4):603-8. PubMed ID: 24339589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.